| Product NDC: | 67457-187 |
| Proprietary Name: | Aloprim |
| Non Proprietary Name: | Allopurinol |
| Active Ingredient(s): | 500 mg/25mL & nbsp; Allopurinol |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67457-187 |
| Labeler Name: | Mylan Institutional LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020298 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960501 |
| Package NDC: | 67457-187-50 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (67457-187-50) > 25 mL in 1 VIAL, GLASS |
| NDC Code | 67457-187-50 |
| Proprietary Name | Aloprim |
| Package Description | 1 VIAL, GLASS in 1 CARTON (67457-187-50) > 25 mL in 1 VIAL, GLASS |
| Product NDC | 67457-187 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Allopurinol |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19960501 |
| Marketing Category Name | NDA |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | ALLOPURINOL |
| Strength Number | 500 |
| Strength Unit | mg/25mL |
| Pharmaceutical Classes | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |